Cara Therapeutics (Tarrytown, NY) is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation has closed a $24M Series C financing. Investors included Scottish Widows Investment Partnership, Mitsubishi International Corporation, MVM Life Science Partners, Alta Partners and Ascent Biomedical Ventures.

Ception Therapeutics (Malvern, PA) a drug company developing anti-inflammatories, raised a $63M Series C round. The financing was led by Essex Woodlands Health Ventures, and was joined by Investor Growth Capital, MDS Life Sciences, New Science Ventures and Aperture Venture Partners.

Conatus Pharmaceuticals (San Diego, CA) a drug developer focused on liver disease, has secured $6.62 million of a $27.37M Series A round. Participants include Aberdare Ventures, Bay City Capital, Advent International and Hale BioPharma Ventures.